Full-Time

Machine Operator 1

Posted on 9/14/2026

Neogen

Neogen

1,001-5,000 employees

Develops and markets food safety tests

Compensation Overview

$23/hr

Lansing, MI, USA

In Person

Category
Manufacturing & Production Operations (1)
Required Skills
GMP

Get referred to Neogen

See people who can refer or advise you

Requirements
  • High school education, up to one month of related experience or training, or an equivalent combination of education and experience.
  • Ability to perform repetitive tasks for extended periods while maintaining attention to detail.
  • Ability to use hands to finger, handle, or feel; reach with hands and arms; and talk or hear, with frequent standing, walking, and sitting.
  • Ability to comply with safety rules, personal protective equipment requirements, equipment-use procedures, and material-disposal requirements.
Responsibilities
  • Operate automated equipment to manufacture, assemble, or move parts, kits, and products.
  • Inspect parts, kits, and products to ensure accuracy.
  • Work at different stations as needed to ensure accuracy.
  • Maintain equipment and facilities, including preventative maintenance of specialized and advanced equipment.
  • Perform tasks according to the appropriate Standard Manufacturing Procedure or Standard Operating Procedure.
  • Follow International Organization for Standardization guidelines in the manufacture of reagents.
  • Use good manufacturing procedures and good documentation practices in the manufacture of reagents.
  • Participate in troubleshooting efforts related to product failures.
  • Participate in product and process improvement for current products and processes.
  • Maintain the cleanliness and organization of work areas using lean processes and 5S.
  • Operate, maintain, and calibrate basic equipment necessary to perform job functions.
  • Plan and execute preparatory processes for scheduled manufacturing duties.
  • Participate in transferring products from Research and Development or Manufacturability Support to Manufacturing.
  • Propose document updates and improvements.
  • Continually maintain and monitor machines to ensure proper function.
  • Aid in supply management.
  • Assist with physical inventories as required.
  • Perform other duties assigned by a supervisor or manager.
  • Comply with and promote corporate handbook policies and corporate and departmental goals, productivity standards, quality expectations, and behavior expectations.

Neogen develops and markets test kits and services to detect a range of safety issues in the food and animal supply chain. Its products help identify foodborne bacteria, natural toxins, and drug residues in animals, and the company divides its offerings into two segments: Food Safety and Animal Safety. Products are delivered as test kits and related services that enable customers to screen and verify safety at various stages from farm to fork. The firm differentiates itself through its scale and geographic reach, a consequence of the 2022 merger with 3M’s food safety business that nearly doubled its size and created a global leader in food safety by expanding product lines and geographic footprint. Neogen’s goal is to ensure the safety of the world’s food supply by providing comprehensive tools and services that detect contaminants and residues across the food and animal industries.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Lansing, Michigan

Founded

1982

Get referred to Neogen

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 30, 2026 revenue reached $225.3 million, and FY2027 guide rose to $880–$885 million.
  • Food Safety core growth hit 5.8% in Q4 fiscal 2026, led by indicator testing.
  • Petrifilm production moves to Lansing in November 2026, supporting margin recovery and launches.

What critics are saying

  • The August 2026 securities class action over the 3M integration remains unresolved.
  • August 2026 ransomware claims from ShinyHunters threaten customer trust and incident costs.
  • A failed 3M integration or repeated quality issues would trap Neogen in low-growth purgatory.

What makes Neogen unique

  • Neogen’s Food Safety and Animal Safety niches focus on testing, not broad diagnostics.
  • Its Petrifilm and molecular assays embed recurring consumable revenue and installed-base switching costs.
  • The March 2026 Zoetis genomics sale sharpens a portfolio around core safety workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

20%
BioKey qPCR
Sep 9th, 2026
blog about Neogen Introduces Rapid Fish Protein Test for Food Safety.

blog about Neogen Introduces Rapid Fish Protein Test for Food Safety. All Products Certification I'm Online Chat Now Company Blog Neogen Introduces Rapid Fish Protein Test for Food Safety In the complex landscape of modern food production, consumer concerns about product safety continue to rise. Hidden risks of cross-contamination during processing pose invisible threats to product purity and public health. Among various food ingredients, undetected fish protein residues present particular challenges due to their potential allergenicity and possible adverse reactions in sensitive consumers. Chapter 1: Core Technology and Superior Performance 1.1 Immunochromatographic Technology: Foundation of Accurate Detection The Neogen(R) Fish Protein Rapid Test Kit employs advanced immunochromatographic technology, leveraging the specific binding reaction between antibodies and antigens. Specially designed antibodies immobilized on the test strip efficiently identify and bind to fish proteins in food samples. 1.2 Qualitative Detection with Content Indication The kit's innovative design features three indicator lines that provide more than simple presence/absence results: * Undetected: Only the control line (C) appears, indicating fish protein content below detection limits. * Low content: Control line (C) and hook line (H) appear, while test line (T) remains faint or invisible. * High content: All three lines (C, H, T) appear, with T-line intensity correlating with fish protein concentration. 1.3 Lateral Flow Device: Efficient Detection Platform The lateral flow device utilizes capillary action for sample movement and reaction, requiring no complex instrumentation. This design enables rapid on-site screening in production facilities, laboratories, or quality control stations. Chapter 2: Key Specifications and Performance Metrics 2.1 Brand and Detection Target Manufactured by Neogen(R), a global leader in food safety solutions, the kit specifically targets fish protein - a common allergen requiring precise detection to meet regulatory requirements and protect sensitive consumers. 2.2 Platform and Result Type The lateral flow platform delivers qualitative results within 11 minutes, providing immediate feedback for production decisions while maintaining high sensitivity at 1 ppm detection limits. 2.3 Storage and Packaging Requiring refrigeration at 2-8°C (36-46°F), each kit contains materials for 25 tests in compact packaging (21.20x14.20x8.00 cm, 0.86 lb), facilitating easy storage and transportation. Chapter 3: Complete Configuration and Streamlined Operation 3.1 Included Components The kit provides a complete detection solution with: * 25 individually packaged test strips * 1 bottle of extraction buffer * 26 dilution tubes (including 1 spare) 3.2 Optional Accessories For optimal performance, users may supplement with: * Environmental sampling swabs * Precision transfer pipettes * Centrifuge for challenging matrices (e.g., chocolate/gum) * Vortex mixer and timer for standardized procedures Chapter 4: Comprehensive Support Services 4.1 Risk Assessment Resources Guidance documents assist in evaluating potential allergen risks using scientifically established reference doses. 4.2 Technical Documentation Multilingual product manuals and safety data sheets ensure proper handling and interpretation across global operations. 4.3 Professional Training Virtual training programs enhance operator competency in test procedures, result interpretation, and quality maintenance, with certification validating acquired skills. 4.4 Technical Support Remote assistance platforms enable real-time troubleshooting, ensuring uninterrupted testing operations worldwide. In an era of heightened food safety awareness, the Neogen(R) Fish Protein Rapid Test Kit represents a technologically advanced solution for preventing allergen cross-contamination. Its combination of accuracy, efficiency, and user-friendly design empowers food producers to maintain rigorous quality standards while protecting consumer health and brand integrity. Pub Time: 2026-09-09 00:00:00 >> Blog list Contact Details Guangzhou BioKey Healthy Technology Co.Ltd Contact Person: Ms. Lisa Send your inquiry directly to Guangzhou BioKey Healthy Technology Co (0 / 3000)

Yahoo Finance
Aug 31st, 2026
Neogen surges 102.8% in a year on R&D investment and food safety growth

Neogen Corporation has surged 102.8% over the past year, significantly outpacing the S&P 500's 21.4% gain and the industry's 24.7% decline. The company develops and markets food and animal safety products. The rally is driven by strong research and development efforts, including new product launches and plans to increase fiscal 2027 R&D spending by approximately 50%. The Food Safety segment showed momentum in Q4 fiscal 2026, with revenues up 3.1% year over year and core growth reaching 5.8%. The Animal Safety business is entering fiscal 2027 with improved supply conditions after resolving third-party supplier issues. Neogen's 2022 merger with 3M's Food Safety business continues to strengthen its portfolio, with Petrifilm production shifting to its Lansing facility. The company holds a Zacks Rank #2 (Buy) rating.

HookPhish
Aug 30th, 2026
Ransomware Group shinyhunters hits: Neogen Corporation.

Ransomware Group shinyhunters hits: Neogen Corporation. HookPhish team Summary. In the latest cybersecurity news, Neogen Corporation - an organization based in US - has fallen victim to a ransomware attack conducted by the group shinyhunters. This data breach, discovered on Aug 29, 2026, 21:01 UTC, underscores the increasing need for proactive cybersecurity defenses as HookPhish continue through 2026. Incident report. | Target Organization | Neogen Corporation | | Threat Group | shinyhunters | | Summary | This is a final warning to reach out by 1 Sep 2026 before HookPhish leak along with several annoying (digital) problems that'll come your way. Make the right decision, don't be the next headline. Updated: 30 Aug 2026 | Warning: FINAL WARNING | | Date of Breach | Aug 29, 2026, 21:01 UTC | | Discovery Date | Aug 29, 2026, 21:01 UTC | | Region | US | | Business Sector | Agriculture and Food Production | How to reduce your ransomware risk. Most ransomware intrusions start with a stolen password or a phishing email. A few proactive steps sharply cut your exposure: * continuous breach monitoring - close the gap attackers exploit. * realistic phishing tests - close the gap attackers exploit. Disclaimer. HookPhish does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.

MarketBeat
Aug 2nd, 2026
Glenmede Trust Co. NA reduces position in Neogen Corporation $NEOG.

Glenmede Trust Co. NA reduces position in Neogen Corporation $NEOG. August 2, 2026 Key points. * Glenmede Trust reduced its Neogen position by 7.3% in the first quarter, selling 144,411 shares and retaining 1.83 million shares valued at approximately $17 million. Institutional investors collectively own 96.73% of the company. * Neogen exceeded fiscal fourth-quarter expectations with adjusted EPS of $0.09 and revenue of $225.3 million, while management forecast fiscal 2027 revenue of $880 million-$885 million and adjusted EBITDA of $180 million-$182 million. * Despite the earnings beat and upbeat outlook, revenue was nearly flat year over year, analysts maintain a consensus "Hold" rating with a $10.67 price target, and planned 50% higher R&D spending could pressure near-term margins. * Interested in Neogen? Here are five stocks we like better. Glenmede Trust Co. NA decreased its holdings in Neogen Corporation (NASDAQ:NEOG - Free Report) by 7.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,829,298 shares of the company's stock after selling 144,411 shares during the period. Glenmede Trust Co. NA owned approximately 0.84% of Neogen worth $16,994,000 at the end of the most recent quarter. A number of other institutional investors have also bought and sold shares of the business. Cibc World Markets Corp purchased a new stake in shares of Neogen in the fourth quarter valued at approximately $47,983,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of Neogen by 249.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company's stock valued at $57,191,000 after purchasing an additional 5,838,570 shares during the last quarter. SG Americas Securities LLC lifted its position in Neogen by 287.4% during the first quarter. SG Americas Securities LLC now owns 6,266,033 shares of the company's stock worth $58,211,000 after buying an additional 4,648,436 shares in the last quarter. Bank of Montreal Can lifted its position in Neogen by 4,059.4% during the third quarter. Bank of Montreal Can now owns 4,592,218 shares of the company's stock worth $26,222,000 after buying an additional 4,481,812 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Neogen by 250.2% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,490,800 shares of the company's stock worth $24,401,000 after buying an additional 2,493,900 shares during the last quarter. 96.73% of the stock is owned by hedge funds and other institutional investors. Key headlines impacting Neogen. Here are the key news stories impacting Neogen this week: * Positive Sentiment: Neogen reported fiscal Q4 adjusted earnings of $0.09 per share, above the $0.05 analyst consensus and substantially better than the $2.82-per-share loss reported in the year-ago quarter. Revenue of $225.3 million also exceeded estimates of $212.35 million. Neogen Beats Q4 Earnings and Revenue Estimates * Positive Sentiment: Management forecast fiscal 2027 revenue of $880 million to $885 million, above the $851.1 million consensus estimate. First-quarter fiscal 2027 revenue guidance of $207 million to $209 million also topped the $204.9 million consensus. Neogen Fiscal 2027 Guidance * Positive Sentiment: The company expects fiscal 2027 adjusted EBITDA of approximately $180 million to $182 million, signaling anticipated improvement in profitability and supporting the favorable investor reaction. Neogen Fiscal 2026 Results * Neutral Sentiment: Despite the earnings beat, quarterly revenue was essentially flat year over year, down 0.1%, indicating that the stronger outlook depends on future growth rather than current top-line acceleration. * Neutral Sentiment: Analysts' average price target is approximately $10.67, below the stock's recent trading level, suggesting valuation and expectations may limit additional upside. Analysts Set Neogen Price Target * Negative Sentiment: Neogen plans to increase research and development spending by roughly 50% in fiscal 2027. Although intended to support longer-term growth, the investment could pressure near-term margins and earnings. Neogen stock performance. NASDAQ:NEOG opened at $12.04 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.84 and a current ratio of 3.82. The stock has a market capitalization of $2.62 billion, a P/E ratio of -401.33, a PEG ratio of 5.39 and a beta of 1.80. The company has a 50 day moving average price of $9.44 and a 200 day moving average price of $9.62. Neogen Corporation has a fifty-two week low of $4.56 and a fifty-two week high of $12.15. Discover more Stock Screener Tool Financial News Subscription Neogen (NASDAQ:NEOG - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. Neogen had a positive return on equity of 2.78% and a negative net margin of 0.91%.The company had revenue of $225.30 million for the quarter, compared to analyst estimates of $212.35 million. During the same quarter in the previous year, the company earned ($2.82) earnings per share. The firm's quarterly revenue was down .1% compared to the same quarter last year. Equities research analysts forecast that Neogen Corporation will post 0.22 EPS for the current year. Analysts Set new price targets. Several brokerages have issued reports on NEOG. Wall Street Zen upgraded Neogen from a "hold" rating to a "buy" rating in a report on Saturday, May 9th. Weiss Ratings lowered Neogen from a "sell (d-)" rating to a "sell (e+)" rating in a report on Friday, July 24th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $10.67. Neogen company profile. Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user-friendly assays to food processors, grain handlers and quality laboratories around the world. In the food safety arena, Neogen's product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E. Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Neogen, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list. While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom.

Yahoo Finance
Aug 1st, 2026
Neogen posts $225M Q4 revenue, targets $880-885M for 2027 despite $7.9M annual loss

Neogen reported a fiscal Q4 net loss of $11.3 million on revenue of $225.3 million and posted a full-year loss of $7.9 million on revenue of $870.4 million. Despite remaining unprofitable, the company sharply reduced losses year-over-year whilst boosting core revenue growth. For fiscal 2027, Neogen issued revenue guidance of $880 million to $885 million. Management plans to increase R&D and transformation spending, partly funded through a planned sale of its Genomics business and debt repayment. The company faces ongoing risks including integration challenges from its 3M acquisition, securities litigation, and recent product quality issues. Neogen is not expected to achieve profitability in the next few years. Community fair value estimates for the stock range widely from roughly $13 to above $33 per share.